发明名称 5,6,-0-Isoalkylidene ascorbic acid derivatives
摘要 Novel condensation products between enediol ketolactones such as 5,6-0-isopropylidene ascorbic acid and 2-chloroethyl isocyanates are shown to have potent antitumor activity probably without the release of alkylating agents in vivo. While the structures of the products are not readily elucidated, activity is found to exceed that of BCNU (bis-(2-chloroethyl)-N-nitrosourea) and parallel that of the toxic and highly effective nitrosourea, MeCCNU (1-(4-trans-methylcyclohexyl)-3-(2-chloroethyl)-3-nitrosourea). Preferred compounds are condensation products of <IMAGE> (A) wherein R2 and R3 are a lower alkyl group containing 1 to 3 carbon atoms or H and hal-CH2-CH2-N=C=O (B) wherein hal is I, Br or Cl.
申请公布号 US4423236(A) 申请公布日期 1983.12.27
申请号 US19810314423 申请日期 1981.10.23
申请人 NATIONAL FOUNDATION FOR CANCER RESEARCH, INC. 发明人 WELEBIR, ANDREW J.
分类号 C07D307/62;C07D407/00;(IPC1-7):C07D407/00 主分类号 C07D307/62
代理机构 代理人
主权项
地址